Metropolis Healthcare Limited

NSEI:METROPOLIS 株式レポート

時価総額:₹111.9b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Metropolis Healthcare 将来の成長

Future 基準チェック /46

Metropolis Healthcare利益と収益がそれぞれ年間24%と11%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に19.6% 23.7%なると予測されています。

主要情報

23.3%

収益成長率

23.8%

EPS成長率

Healthcare 収益成長26.4%
収益成長率11.2%
将来の株主資本利益率18.1%
アナリストカバレッジ

Good

最終更新日21 Aug 2024

今後の成長に関する最新情報

Metropolis Healthcare Limited (NSE:METROPOLIS) Just Reported And Analysts Have Been Lifting Their Price Targets

Aug 14
Metropolis Healthcare Limited (NSE:METROPOLIS) Just Reported And Analysts Have Been Lifting Their Price Targets

Metropolis Healthcare Limited Just Missed EPS By 5.7%: Here's What Analysts Think Will Happen Next

May 24
Metropolis Healthcare Limited Just Missed EPS By 5.7%: Here's What Analysts Think Will Happen Next

Recent updates

Metropolis Healthcare Limited (NSE:METROPOLIS) Just Reported And Analysts Have Been Lifting Their Price Targets

Aug 14
Metropolis Healthcare Limited (NSE:METROPOLIS) Just Reported And Analysts Have Been Lifting Their Price Targets

Metropolis Healthcare Limited Just Missed EPS By 5.7%: Here's What Analysts Think Will Happen Next

May 24
Metropolis Healthcare Limited Just Missed EPS By 5.7%: Here's What Analysts Think Will Happen Next

Why Investors Shouldn't Be Surprised By Metropolis Healthcare Limited's (NSE:METROPOLIS) P/E

Mar 28
Why Investors Shouldn't Be Surprised By Metropolis Healthcare Limited's (NSE:METROPOLIS) P/E

Capital Allocation Trends At Metropolis Healthcare (NSE:METROPOLIS) Aren't Ideal

Jan 13
Capital Allocation Trends At Metropolis Healthcare (NSE:METROPOLIS) Aren't Ideal

Metropolis Healthcare Limited's (NSE:METROPOLIS) Share Price Matching Investor Opinion

Dec 23
Metropolis Healthcare Limited's (NSE:METROPOLIS) Share Price Matching Investor Opinion

Does Metropolis Healthcare (NSE:METROPOLIS) Have A Healthy Balance Sheet?

Sep 08
Does Metropolis Healthcare (NSE:METROPOLIS) Have A Healthy Balance Sheet?

Metropolis Healthcare (NSE:METROPOLIS) Could Be Struggling To Allocate Capital

Jun 20
Metropolis Healthcare (NSE:METROPOLIS) Could Be Struggling To Allocate Capital

Metropolis Healthcare (NSE:METROPOLIS) Might Be Having Difficulty Using Its Capital Effectively

Mar 14
Metropolis Healthcare (NSE:METROPOLIS) Might Be Having Difficulty Using Its Capital Effectively

Metropolis Healthcare's (NSE:METROPOLIS) Dividend Will Be ₹8.00

Feb 13
Metropolis Healthcare's (NSE:METROPOLIS) Dividend Will Be ₹8.00

Metropolis Healthcare Limited's (NSE:METROPOLIS) Intrinsic Value Is Potentially 25% Below Its Share Price

Sep 25
Metropolis Healthcare Limited's (NSE:METROPOLIS) Intrinsic Value Is Potentially 25% Below Its Share Price

Is Metropolis Healthcare (NSE:METROPOLIS) A Risky Investment?

Sep 10
Is Metropolis Healthcare (NSE:METROPOLIS) A Risky Investment?

Metropolis Healthcare (NSE:METROPOLIS) Has A Rock Solid Balance Sheet

Jun 07
Metropolis Healthcare (NSE:METROPOLIS) Has A Rock Solid Balance Sheet

Capital Investments At Metropolis Healthcare (NSE:METROPOLIS) Point To A Promising Future

May 16
Capital Investments At Metropolis Healthcare (NSE:METROPOLIS) Point To A Promising Future

Is Now The Time To Put Metropolis Healthcare (NSE:METROPOLIS) On Your Watchlist?

Mar 17
Is Now The Time To Put Metropolis Healthcare (NSE:METROPOLIS) On Your Watchlist?

Capital Investments At Metropolis Healthcare (NSE:METROPOLIS) Point To A Promising Future

Jan 29
Capital Investments At Metropolis Healthcare (NSE:METROPOLIS) Point To A Promising Future

Do Metropolis Healthcare's (NSE:METROPOLIS) Earnings Warrant Your Attention?

Dec 14
Do Metropolis Healthcare's (NSE:METROPOLIS) Earnings Warrant Your Attention?

Metropolis Healthcare (NSE:METROPOLIS) Looks To Prolong Its Impressive Returns

Oct 12
Metropolis Healthcare (NSE:METROPOLIS) Looks To Prolong Its Impressive Returns

Should You Be Adding Metropolis Healthcare (NSE:METROPOLIS) To Your Watchlist Today?

Aug 27
Should You Be Adding Metropolis Healthcare (NSE:METROPOLIS) To Your Watchlist Today?

Here's What Metropolis Healthcare's (NSE:METROPOLIS) Strong Returns On Capital Mean

Jul 06
Here's What Metropolis Healthcare's (NSE:METROPOLIS) Strong Returns On Capital Mean

I Ran A Stock Scan For Earnings Growth And Metropolis Healthcare (NSE:METROPOLIS) Passed With Ease

May 28
I Ran A Stock Scan For Earnings Growth And Metropolis Healthcare (NSE:METROPOLIS) Passed With Ease

Metropolis Healthcare (NSE:METROPOLIS) Is Aiming To Keep Up Its Impressive Returns

Mar 29
Metropolis Healthcare (NSE:METROPOLIS) Is Aiming To Keep Up Its Impressive Returns

Does Metropolis Healthcare's (NSE:METROPOLIS) Share Price Gain of 15% Match Its Business Performance?

Mar 11
Does Metropolis Healthcare's (NSE:METROPOLIS) Share Price Gain of 15% Match Its Business Performance?

業績と収益の成長予測

NSEI:METROPOLIS - アナリストの将来予測と過去の財務データ ( )INR Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
3/31/202717,3892,6663,299N/A13
3/31/202615,4752,2752,809N/A17
3/31/202513,6481,7972,370N/A16
6/30/202412,4401,370N/AN/AN/A
3/31/202412,0771,2782,0032,641N/A
12/31/202311,5931,248N/AN/AN/A
9/30/202311,5361,3341,7182,183N/A
6/30/202311,4541,383N/AN/AN/A
3/31/202311,4821,4291,9452,471N/A
12/31/202211,7161,495N/AN/AN/A
9/30/202211,7921,5481,7542,266N/A
6/30/202211,8141,727N/AN/AN/A
3/31/202212,2832,1422,2262,533N/A
12/31/202112,1422,355N/AN/AN/A
9/30/202111,9592,5312,9243,195N/A
6/30/202111,8162,551N/AN/AN/A
3/31/20219,9801,8312,2082,490N/A
12/31/20209,1321,372N/AN/AN/A
9/30/20208,6131,2071,7562,059N/A
6/30/20207,9621,034N/AN/AN/A
3/31/20208,5641,2731,7882,150N/A
12/31/20198,5131,463N/AN/AN/A
9/30/20198,1891,3551,0201,341N/A
6/30/20197,8871,230N/AN/AN/A
3/31/20197,6121,201664902N/A
3/31/20186,4721,042N/A1,039N/A
3/31/20175,4471,017N/A1,018N/A
3/31/20164,755768N/A914N/A
3/31/20154,555610N/A695N/A
3/31/20143,883566N/A769N/A

アナリストによる今後の成長予測

収入対貯蓄率: METROPOLISの予測収益成長率 (年間24% ) は 貯蓄率 ( 6.7% ) を上回っています。

収益対市場: METROPOLISの収益 ( 24% ) はIndian市場 ( 16% ) よりも速いペースで成長すると予測されています。

高成長収益: METROPOLISの収益は今後 3 年間で 大幅に 増加すると予想されています。

収益対市場: METROPOLISの収益 ( 11% ) Indian市場 ( 9.6% ) よりも速いペースで成長すると予測されています。

高い収益成長: METROPOLISの収益 ( 11% ) 20%よりも低い成長が予測されています。


一株当たり利益成長率予想


将来の株主資本利益率

将来のROE: METROPOLISの 自己資本利益率 は、3年後には低くなると予測されています ( 19.6 %)。


成長企業の発掘